Skip to content

Minimally Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis

Minimally Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis (MITOSIS-Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00888212
Acronym
MITOSIS
Enrollment
100
Registered
2009-04-27
Start date
2008-06-30
Completion date
2009-06-30
Last updated
2009-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis

Brief summary

The purpose of this study is to evaluate the yield of endoscopic guided fine needle aspirations (by means of transoesophageal endoscopic ultrasound : EUS-FNA or transbronchial endoscopic ultrasound : EBUS-TBNA) in patients with a clinical suspicion for sarcoidosis stage I-II; but in whom the preceding bronchoscopy did not result in a qualifying diagnosis.

Interventions

PROCEDUREBronchoscopy

Bronchoscopy, only if no diagnosis is obtained, patients go for EUS-FNA or EBUS-TBNA, only if no diagnosis is obtained, patients go for surgical biopsy

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 y * Suspicion of thoracic sarcoidosis and need for tissue confirmation * Recent (\<6 weeks) RX and CT-thorax (HRCT not compulsory) * Fit for bronchoscopy (with or without EBB, TBB, TBNA), esophagoscopy and surgery * Written informed consent

Exclusion criteria

* Patients with obvious other organ involvement allowing simple and safe biopsy * Lofgren syndrome * Pregnancy

Design outcomes

Primary

MeasureTime frame
The diagnostic yield of state-of-the art bronchoscopy (including TBB, EBB and TBNA)At the end of study
The role of endosonography (EUS-FNA or EBUS-TBNA) in demonstrating non-caseating granulomas after a non-qualifying bronchoscopyAt the end of study

Secondary

MeasureTime frame
Prevalence of sarcoidosis and alternate diagnosisAt the end of study
Stage distributionAt the end of study
Complication rate of each type of procedureAt the end of study
Cost to obtain a qualifying diagnosis with this strategy in this populationAt the end of study

Countries

Belgium, Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026